Morpholino

MO1-ube2ia

ID
ZDB-MRPHLNO-061227-2
Name
MO1-ube2ia
Previous Names
None
Target
Sequence
5' - GACGACTCAATGCTATACCAGACAT - 3'
Disclaimer
Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.
Note
None
Genome Resources
None
Target Location
Genomic Features
No data available
Expression
Gene expression in Wild Types + MO1-ube2ia
Phenotype
Phenotype resulting from MO1-ube2ia
No data available
Phenotype of all Fish created by or utilizing MO1-ube2ia
Phenotype Fish Conditions Figures
anterior lateral plate mesoderm nkx2.5 expression decreased amount, abnormal ube2ibrj828/rj828 + MO1-ube2ia standard conditions Fig. 5 from Wen et al., 2017
anterior lateral plate mesoderm gata4 expression decreased amount, abnormal ube2ibrj828/rj828 + MO1-ube2ia standard conditions Fig. 5 from Wen et al., 2017
anterior lateral plate mesoderm nkx2.5 expression increased distribution, abnormal ube2ibrj828/rj828 + MO1-ube2ia standard conditions Fig. 5 from Wen et al., 2017
heart tube shortened, abnormal ube2ibrj828/rj828 + MO1-ube2ia standard conditions Fig. S5 from Wen et al., 2017
anterior lateral plate mesoderm gata5 expression decreased amount, abnormal ube2ibrj828/rj828 + MO1-ube2ia standard conditions Fig. 5 from Wen et al., 2017
anterior lateral plate mesoderm mef2cb expression decreased amount, abnormal ube2ibrj828/rj828 + MO1-ube2ia standard conditions Fig. 5 from Wen et al., 2017
anterior lateral plate mesoderm mef2cb expression increased distribution, abnormal ube2ibrj828/rj828 + MO1-ube2ia standard conditions Fig. 5 from Wen et al., 2017
heart looping disrupted, abnormal ube2ibrj828/rj828 + MO1-ube2ia standard conditions Fig. S5 from Wen et al., 2017
thymus lymphoid progenitor cell aplastic, abnormal WT + MO1-ube2ia + MO2-ube2ib standard conditions Fig. 2 with image from Yuan et al., 2015
myeloid cell decreased amount, abnormal WT + MO1-ube2ia + MO2-ube2ib standard conditions Fig. 2 with image from Yuan et al., 2015
erythroid lineage cell decreased amount, abnormal WT + MO1-ube2ia + MO2-ube2ib standard conditions Fig. 2 with image from Yuan et al., 2015
hematopoietic multipotent progenitor cell decreased amount, abnormal WT + MO1-ube2ia + MO2-ube2ib standard conditions Fig. 1 with image from Yuan et al., 2015
thymus lymphoid progenitor cell absent, abnormal WT + MO1-ube2ia + MO2-ube2ib standard conditions Fig. 2 with image from Yuan et al., 2015
hematopoietic multipotent progenitor cell decreased amount, abnormal WT + MO1-ube2ia + MO2-ube2ib + MO7-tp53 standard conditions Fig. 1 with image from Yuan et al., 2015
hematopoietic multipotent progenitor cell cell population proliferation decreased process quality, abnormal zf169Tg + MO1-ube2ia + MO2-ube2ib standard conditions Fig. 3 with image from Yuan et al., 2015
Citations